FARMACOCINÉTICA EXPERIMENTAL Y CLÍNICA
Hospital Universitario de Salamanca
Salamanca, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Salamanca (200)
2024
-
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74
2023
-
Analysis of the degree of implementation of medication error prevention practices in Spanish hospitals (2022)
Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 268-276
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Medication delivery errors in outpatients with percutaneous endoscopic gastrostomy: effect on tube feeding replacement
Scientific Reports, Vol. 13, Núm. 1
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
-
Validation and clinical evaluation of an ultra-performance liquid chromatography with ultraviolet detector method for plasma quantification of micafungin
Annals of Clinical Biochemistry, Vol. 60, Núm. 3, pp. 191-198
2022
-
External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia
British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1913-1924
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease
European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 222-227
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients
Pharmaceutics, Vol. 14, Núm. 4
-
Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients
European Journal of Pharmaceutical Sciences, Vol. 168
-
Process of medical nutrition therapy
Nutricion Hospitalaria, Vol. 39, Núm. 5, pp. 1166-1189
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
Comparison of ultra-performance liquid chromatography and ARK immunoassay for therapeutic drug monitoring of voriconazole
Annals of Clinical Biochemistry, Vol. 58, Núm. 6, pp. 657-660
-
Estudio multicéntrico de la incidencia y evitabilidad de los incidentes por medicamentos en pacientes que acuden a los servicios de urgencias pediátricas
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 3, pp. 115-120
-
Evaluation of current amikacin dosing recommendations and development of an interactive nomogram: The role of albumin
Pharmaceutics, Vol. 13, Núm. 2, pp. 1-13
-
Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity
European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E41-E46
-
Validation and Comparison of Two Analytical Methods for Imatinib Therapeutic Drug Monitoring
Chromatographia, Vol. 84, Núm. 6, pp. 589-596
-
Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds
International Journal of Clinical Pharmacy, Vol. 43, Núm. 4, pp. 1123-1127